In vitro effects of cobalt nanoparticles on aspartate aminotransferase and alanine aminotransferase activities of wistar rats

Biao, 2005, Preparation of nanometer cobalt particles by polyol reduction process and mechanism research, Mater. Trans., 46, 1865, 10.2320/matertrans.46.1865 Ha, 2018, Recent advances incorporating superparamagnetic nanoparticles into immunoassays, ACS Appl. Nano Mater., 1, 512, 10.1021/acsanm.7b00025 Faraji, 2010, Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications, J. Iran. Chem. Soc., 7, 1, 10.1007/BF03245856 Tartaj, 2003, The preparation of magnetic nanoparticles for applications in biomedicine, J. Phys. D Appl. Phys., 36, 182, 10.1088/0022-3727/36/13/202 Czarnek, 2015, Selected aspects of the action of cobalt ions in the human body, Cent. J. Immunol., 40, 236, 10.5114/ceji.2015.52837 Rubins, 1999, Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol, N. Engl. J. Med., 341, 410, 10.1056/NEJM199908053410604 Huang, 2006, Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques, Sensors., 6, 756, 10.3390/s6070756 Lieber, 2003, Veterans affairs cooperative study of polyenylphosphatidylcholine in alcoholic liver disease, Alcohol. Clin. Environ. Res., 27, 1765, 10.1097/01.ALC.0000093743.03049.80 Lieber, 2000, Alcoholic liver disease: new insights in pathogenesis lead to new treatments, J. Hepatol., 32, 113, 10.1016/S0168-8278(00)80420-1 Mowe, 1996, Increased levels of alcohol markers (γGT, MCV, ASAT, ALAT) in older patients are not related to high alcohol intake, J. Am. Geriastrics Soc., 44, 1136, 10.1111/j.1532-5415.1996.tb02960.x Liappas, 2007, Vitamin B12 and hepatic enzyme serum levels correlate with interleukin-6 in alcohol-dependent individuals without liver disease, Clin. Biochem., 40, 781, 10.1016/j.clinbiochem.2007.03.002 Gowda, 2009, A review on laboratory liver function tests, Pan Afr. Med. J., 3, 1 Giannini, 2005, Liver enzyme alteration: a guide for clinicians, Can. Med. Assoc. J., 172, 367, 10.1503/cmaj.1040752 Hall, 2012, What is the real function of the liver “function” tests?, Ulster Med. J., 81, 30 Horev-Azaria, 2011, Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data, Toxicol. Sci., 122, 489, 10.1093/toxsci/kfr124 Monteiller, 2007, The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area, Occup. Environ. Med., 64, 609, 10.1136/oem.2005.024802 Papageorgiou, 2007, The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro, Biomaterials., 28, 2946, 10.1016/j.biomaterials.2007.02.034 Peters, 2004, Effects of nano-scaled particles on endothelial cell function in vitro Studies on viability, proliferation and inflammation, J. Mater. Sci. Mater. Med., 15, 321, 10.1023/B:JMSM.0000021095.36878.1b Papis, 2007, Gene expression in nanotoxicology research: analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions, Toxicol. Lett., 170, 185, 10.1016/j.toxlet.2007.03.005 Colognato, 2008, Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro, Mutagenesis., 23, 377, 10.1093/mutage/gen024 Goldberg, 1988, The Diagnostic accuracy of three recommended methods for serum aspartate aminotransferase assays in patients suspected of myocardial infarction and hepatobiliary diseases, Clin. Biochem., 21, 323, 10.1016/S0009-9120(88)80090-0 Gella, 1985, A simple procedure for the routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate, Clin. Chim. Acta, 153, 241, 10.1016/0009-8981(85)90358-4 Lustig, 1988, Evaluation of commercially formulated aspartate aminotransferase and alanine aminotransferase activity determinations by the scandinavian committee on enzymes and IFCC methods as modified for use with automated enzyme analysers, Clin. Biochem., 21, 283, 10.1016/S0009-9120(88)80082-1 Vagvala, 2018, Imaging of abnormal liver function tests, Clin. Liver Dis., 11, 128, 10.1002/cld.704 Green, 2002, AGA technical review on the evaluation of liver chemistry tests, Gastroenterology., 123, 1367, 10.1053/gast.2002.36061 Jung, 1977, Comparative determinations of aminotransferase activities in serum with so-called “optimised” methods, Clin. Chim. Acta, 81, 299, 10.1016/0009-8981(77)90064-X Bacq, 1996, Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls, Hepatology, 23, 1030, 10.1002/hep.510230514 Kamath, 1996, Clinical approach to the patient with abnormal liver test results, Mayo Clin. Proc., 71, 1089, 10.4065/71.11.1089 Lowry, 1951, Protein measurement with the folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Yatzidis, 1974, New method for direct determination of “True” creatinine, Clin. Chem., 20, 1131, 10.1093/clinchem/20.9.1131 Adams, 2010, Mechanisms of immune-mediated liver injury, Toxicol. Sci., 115, 307, 10.1093/toxsci/kfq009 De Boeck, 2003, Cobalt and antimony: genotoxicity and carcinogenicity, Mutat. Res., 533, 135, 10.1016/j.mrfmmm.2003.07.012 Liu, 2016, Cytotoxicity and genotoxicity in liver cells induced by cobalt nanoparticles and ions, Bone Jt. Res., 5, 461, 10.1302/2046-3758.510.BJR-2016-0016.R1 Machado, 2012, Arthroprosthetic cobaltism and cardiomyopathy, Hear. Lung Circ., 21, 759, 10.1016/j.hlc.2012.03.013 Oldenburg, 2009, Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty, J. Arthroplasty, 24, 825, 10.1016/j.arth.2008.07.017 Pelclova, 2012, Severe cobalt intoxication following hip replacement revision: clinical features and outcome, Clin. Toxicol., 50, 262, 10.3109/15563650.2012.670244 Bossi, 2016, Cobalt oxide nanoparticles can enter inside the cells by crossing plasma membranes, Sci. Rep., 6, 22254, 10.1038/srep22254 Kwon, 2009, Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages in vitro, Biomed. Mater., 4, 10.1088/1748-6041/4/2/025018 Liu, 2015, Toxicity and bioactivity of cobalt nanoparticles on the monocytes, Orthop. Surg., 7.2, 168, 10.1111/os.12180 Akhtar, 2018, Toxicity of PEG-Coated CoFe 2 O 4 nanoparticles with treatment effect of curcumin, Nanoscale Res. Lett., 13.1, 52, 10.1186/s11671-018-2468-7 Nikolov, 2010, Tissue accumulation of lanthanum as compared to aluminum in rats with chronic renal failure - Possible harmful effects after long-term exposure, Nephron - Exp. Nephrol., 115, e112, 10.1159/000313492 Kumari, 2016, Hepatotoxicity and ultra structural changes in wistar rats treated with Al2O3 nanomaterials, Trends Cells Mol. Biol., 11, 77 Schrand, 2010, Metal-based nanoparticles and their toxicity assessment, WIREs Nanomedicine and Nanobiotechnology., 2, 544, 10.1002/wnan.103 Harrison, 1999, Airway nerves and protein phosphatases, Gen. Pharmacol., 32, 287, 10.1016/S0306-3623(98)00204-3 Jakobsen, 2007, Cobalt-chromium-molybdenum alloy causes metal accumulation and metallothionein up-regulation in rat liver and kidney, Basic Clin. Pharmacol. Toxicol., 101, 441, 10.1111/j.1742-7843.2007.00137.x Day, 2006, Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease, Liver Int., 26, 1021, 10.1111/j.1478-3231.2006.01323.x David, 2013, DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy mice, Mol. Ther. - Nucleic Acids., 2, e64, 10.1038/mtna.2012.56 Ding, 2011, The emerging role of autophagy in alcoholic liver disease, Exp. Biol. Med., 236, 546, 10.1258/ebm.2011.010360